Hypertension control and care at Mulago Hospital ambulatory clinic, Kampala-Uganda

[1]  O. Omole,et al.  Factors associated with blood pressure control among patients attending the outpatient clinic of a South African district hospital , 2015, Tropical doctor.

[2]  P. Lwabi,et al.  Microalbuminuria and left ventricular hypertrophy among newly diagnosed black African hypertensive patients: a cross sectional study from a tertiary hospital in Uganda , 2015, BMC Research Notes.

[3]  Timothy Amukele,et al.  A 4-year survey of the spectrum of renal disease at a National Referral Hospital Outpatient Clinic in Uganda. , 2015, Kidney international.

[4]  R. Akehurst,et al.  Cost Effectiveness of Renal Denervation Therapy for the Treatment of Resistant Hypertension in the UK , 2014, Applied Health Economics and Health Policy.

[5]  Deepak L. Bhatt,et al.  Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety , 2014, The New England journal of medicine.

[6]  Jackson T. Wright,et al.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.

[7]  R. Wanyenze,et al.  Hypertension awareness, treatment and control in Africa: a systematic review , 2013, BMC Cardiovascular Disorders.

[8]  G. Musinguzi,et al.  Prevalence, Awareness and Control of Hypertension in Uganda , 2013, PloS one.

[9]  Joshua T. Cohen,et al.  Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. , 2012, Journal of the American College of Cardiology.

[10]  Gregory S Kabadi,et al.  Stroke incidence in rural and urban Tanzania: a prospective, community-based study , 2010, The Lancet Neurology.

[11]  D. Guwatudde,et al.  Prevalence factors associated with hypertension in Rukungiri district, Uganda--a community-based study. , 2009, African health sciences.

[12]  K. Fiscella,et al.  Racial Disparity in Hypertension Control: Tallying the Death Toll , 2008, The Annals of Family Medicine.

[13]  R. Townsend,et al.  What is the proper workup of a patient with hypertension? , 2008, Cleveland Clinic journal of medicine.

[14]  F. Arogundade,et al.  CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  B. Davis,et al.  Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial , 2006, Hypertension.

[16]  M. Glickman,et al.  The effect of age on hypertension control and management. , 2006, American journal of hypertension.

[17]  Alan D. Lopez,et al.  Global burden of disease and risk factors , 2006 .

[18]  A. Menanga,et al.  Nouveau regard sur l'insuffisance cardiaque chronique de l'adulte en Afrique à l'ère de l'échocardiographie Doppler : expérience du service de médecine de l'Hôpital Général de Yaoundé , 2005 .

[19]  K. Reynolds,et al.  Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.

[20]  F. Zannad,et al.  Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach , 2004, Journal of hypertension.

[21]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[22]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[23]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[24]  G. Brundtland.  Reducing Risks to Health, Promoting Healthy Life , 2002 .

[25]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[26]  B. Psaty,et al.  Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension , 2001, Annals of Internal Medicine.

[27]  A. Dyer,et al.  Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. , 1999, JAMA.

[28]  R. Beaglehole.  Cardiovascular disease in developing countries. , 1993, BMJ.

[29]  R. Beaglehole.  Cardiovascular disease in developing countries. , 1992, BMJ.

[30]  C. Agyemang,et al.  Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa , 2006, Journal of Human Hypertension.

[31]  A. Ménanga,et al.  [A new look at adult chronic heart failure in Africa in the age of the Doppler echocardiography: experience of the medicine department at Yaounde General Hospital]. , 2005, Annales de cardiologie et d'angeiologie.